CompletedPhase 2NCT03506061

Trikafta in Cystic Fibrosis Patients

Studying Cystic fibrosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Emory University
Principal Investigator
Eric Sorscher, MD
Emory University
Intervention
Trikafta(drug)
Enrollment
42 enrolled
Eligibility
12 years · All sexes
Timeline
20192024

Study locations (2)

Collaborators

National Heart, Lung, and Blood Institute (NHLBI) · Cystic Fibrosis Foundation · The University of Texas Health Science Center, Houston

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03506061 on ClinicalTrials.gov

Other trials for Cystic fibrosis

Additional recruiting or active studies for the same condition.

See all trials for Cystic fibrosis

← Back to all trials